BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 6804931)

  • 1. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
    Haïat R; Bugugnani MJ
    Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Accuracy of HDL-cholesterol and HDL-apolipoprotein A-I determinations after phosphotungstate/MgCl2-precipitation of apolipoprotein B-containing lipoproteins (author's transl)].
    Assmann G; Schriewer H; Funke H
    J Clin Chem Clin Biochem; 1981 May; 19(5):273-8. PubMed ID: 6790659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A rapid method for continuous flow measurement of cholesterol contained in high density lipoproteins (HDL) (author's transl)].
    Ponsot P; Yvert JP; Chevrier M; Bon R
    Ann Biol Clin (Paris); 1981; 39(5):289-93. PubMed ID: 7316254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
    Orso Giacone G
    Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interpretation of B and A apoproteins dosage in the acute accidents of the cerebral and coronary atherosclerosis. Age influence upon the results (author's transl)].
    Bugugnani MJ; Haiat R; Fouyé H; Rémy A; Desoutter P
    Ann Biol Clin (Paris); 1981; 39(3):131-4. PubMed ID: 6787958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
    Tedeschi-Reiner E; Reiner Z; Sonicki Z
    Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phenobarbital on serum high density lipoprotein subfractions and apolipoproteins.
    Luoma PV; Marniemi J; Sotaniemi EA
    Res Commun Chem Pathol Pharmacol; 1988 Oct; 62(1):125-8. PubMed ID: 3144720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipids, lipoproteins and apolipoproteins in normal newborns].
    Casanueva V; Cid X; Chiang MT; Molina M; Ferrada MC; Pérez R; Casanueva P
    Rev Med Chil; 1998 Sep; 126(9):1073-8. PubMed ID: 9922510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vitamin E megadoses and their effect on HDL cholesterol levels in patients with atherosclerotic complications (author's transl)].
    Turay J; Beseda I; Michalcová A
    Cas Lek Cesk; 1981 Dec; 120(48):1432-4. PubMed ID: 6947861
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reference values for apolipoproteins and HDL-2/HDL-3 in childhood].
    Schulze S; Dörner K
    Klin Padiatr; 1992; 204(2):102-6. PubMed ID: 1583847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-density-lipoprotein and renal insufficiency (author's transl)].
    Graf H; Stummvoll HK; Müller MM
    Wien Klin Wochenschr; 1982 Jan; 94(2):39-41. PubMed ID: 7080495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
    Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
    Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum HDL-cholesterol, apo-A-I and apo-E levels in patients with abnormal coronary arteries.
    Tan MH; Weldon KL; Albers JJ; Cheung MC; Havel RJ; Vigne JL
    Clin Invest Med; 1980; 3(3-4):225-32. PubMed ID: 6784991
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoproteins as markers and managers of coronary risk.
    Chan DC; Watts GF
    QJM; 2006 May; 99(5):277-87. PubMed ID: 16504986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The LDL-HDL ratio in patients with coronary arteriosclerosis (author's transl)].
    Zimmer F; Riebeling V; Benke B; Schuster J; Roskamm H
    Z Kardiol; 1980 Mar; 69(3):149-53. PubMed ID: 7456590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
    Yanni AE; Perrea DN; Yatzidis HA
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.